News

hospital patient in distress crying
Replaceable doctors, online-only doctors, Dr. Thomas Keane & more healthcare AI news in brief

Medical misdiagnoses account for almost 800,000 deaths and other serious harms every year. Meanwhile healthcare AI is roundly celebrated for its diagnostic prowess. Can’t it help cut out a couple hundred thousand of those horrible mistakes?

Medtronic’s MiniMed 780G automated insulin delivery system
Medtronic’s diabetes spin-off files for IPO

Make way for MiniMed! Medtronic's diabetes division has filed the necessary paperwork to go public. The company hopes to be traded on Nasdaq under the symbol MMED.

warning safety alert recall healthcare issue
Bleeding reversal agent pulled from market over FDA’s safety concerns

AstraZeneca has stopped selling Andexxa because randomized data suggested some patients may face an increased risk of certain adverse events. The company emphasized that it remains confident in the agent's abilities.

Abbott Volt Pulsed Field Ablation
Abbott PFA system gains FDA approval

The Volt Pulsed Field Ablation System from Abbott has been approved by the FDA. The technology, which gained CE mark approval in March, features a one-of-a-kind catheter design and allows patients to be treated under conscious sedation.

artificial intelligence money finance acquisition
HHS seeks input on how reimbursement, regulation could bolster use of healthcare AI

The key agency released a request for information on Dec. 19, asking for broad input on how it can accelerate the adoption of AI in clinical care. 

money court scale of justice ruling legal settlement
Rayus Radiology agrees to class action settlement in case over alleged website tracking

Patients first sued the St. Louis Park, Minnesota-based imaging group in two separate lawsuits, both filed in 2023, over its use of tracking pixels to allegedly filter info to Facebook and other third parties. 

Thumbnail
Short-selling investment startup accuses RadNet of exaggerating its success

Founded in 2023, Hunterbrook is an investigative news and investment outlet, which creates reports criticizing publicly traded companies and then benefits from the corresponding drop in share prices

Thumbnail
New iron-based imaging agent significantly improves brain tumor visualization

Ferumoxytol is used primarily in medications that treat anemia, but the FDA recently cleared it for deployment in brain imaging as well.

Mayo Clinic sued after transplant patient dies of meth overdose

An exclusive report from local NBC affiliate KARE 11 tells the story of Noah Leopold, a man who died after receiving two new hearts. The first deteriorated, and the second one killed him. Now, his family is suing, saying the Mayo Clinic failed to inform them of the risks. The nonprofit health system denies the allegations. 

Lady Justice
High-level briefing: Regional merger scrapped | Provider chain denied | Holiday inspiration appreciated | more

The biggest investor in a nursing home chain can run but not hide from comeuppance for the chain’s alleged role in harms—including deaths—done to hundreds of patients.

FDA approves new drug for genetic heart disease

Cytokinetics has secured FDA approval for aficamten, its new drug for the treatment of symptomatic obstructive HCM. Aficamten will be sold under the brand name Myqorzo. 

A diabetic foot ulcer that does not heal due to low blood supply from peripheral artery disease (PAD), and the before and after interventional angiograms of the patient's revascularization treatment. Images courtesy of Foluso Fakorede, MD
ACC calls for better management of peripheral artery disease in diabetic patients

PAD in patients with diabetes is common and associated with an increased risk of several adverse events. A new guidance from the American College of Cardiology reviewed this topic at length, identifying areas where care needs to improve.

Around the web

Health Exec
Replaceable doctors, online-only doctors, Dr. Thomas Keane & more healthcare AI news in brief

Medical misdiagnoses account for almost 800,000 deaths and other serious harms every year. Meanwhile healthcare AI is roundly celebrated for its diagnostic prowess. Can’t it help cut out a couple hundred thousand of those horrible mistakes?

Cardiovascular Business
Medtronic’s diabetes spin-off files for IPO

Make way for MiniMed! Medtronic's diabetes division has filed the necessary paperwork to go public. The company hopes to be traded on Nasdaq under the symbol MMED.

Cardiovascular Business
Bleeding reversal agent pulled from market over FDA’s safety concerns

AstraZeneca has stopped selling Andexxa because randomized data suggested some patients may face an increased risk of certain adverse events. The company emphasized that it remains confident in the agent's abilities.

Design by Adaptive Theme